A Retrospective Single-Center Study of Sevelamer Hydrochloride for the Treatment of Hyperphosphatemia in Children With Tumor Lysis Syndrome

Introduction Tumor lysis syndrome (TLS) is a life-threatening metabolic abnormality. The incidence of TLS depends on the underlying malignancy. In a recent analysis of hematological malignancy, the incidence of clinical TLS in children was 3.8%, laboratory TLS 46.2%, and hyperphosphatemia 32.7%. Sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Blewi, Sawsan M, AlAzmi, Aeshah A, Elimam, Nagla, Jastaniah, Wasil, Mohammedkhalil, Abdullah, Abdullah, Shaker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906967/
https://www.ncbi.nlm.nih.gov/pubmed/36779104
http://dx.doi.org/10.7759/cureus.33533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906967/
https://www.ncbi.nlm.nih.gov/pubmed/36779104
http://dx.doi.org/10.7759/cureus.33533

Ejemplares similares